Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
horizontal line  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Topic
Topic Home
  What Everyone
Should Know & Do
  About Antibiotic
Resistance
  Healthcare Providers
  Partners
  Program Planners
  Media
  Campaign Info
  News & Highlights
  Campaign Materials
  Related CDC Programs
  References & Resources
  First Time Visitor
  Glossary
  Site Map
 Información en Español
Infórmese: Automedicarse con antibióticos puede perjudar su salud
Contact Info
 

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760
Email: cdcinfo@cdc.gov

International Travel
Phone:
1-887-394-8747

_
Get Smart: Know When Antibiotics Work

Acute Pharyngitis in Adults:
Physician Information Sheet (Adults)

Principles apply to the diagnosis and treatment of Group A ß-hemolytic streptococcal (GABHS)
pharyngitis in otherwise healthy adults.

Clinical screening for GABHS pharyngitis could substantially reduce unnecessary antibiotic use.

Background
  • Only 5-15% of adult cases of acute pharyngitis are caused by GABHS.
  • It is estimated that 3,000 to 4,000 patients with GABHS must be treated for every 1 case of acute rheumatic fever prevented.
  • Antibiotic therapy of GABHS hastens resolution by 1-2 days if initiated within 2-3 days of symptom onset.
Diagnosis
  • Lab testing is not indicated in all patients with pharyngitis. Instead, all adults should be screened for the following:
    • History of fever
    • Lack of cough
    • Tonsillar exudates
    • Tender anterior cervical adenopathy
  • Patients with none or only one of these findings should not be tested or treated for GABHS.
  • Any one of the following three strategies is appropriate for patients with two or more of the above findings:
    • Rapid streptococcal antigen test (RAT) for patients with 2 or more criteria, with antibiotic therapy restricted to those with positive test results.
    • Rapid streptococcal antigen testing of patients with 2 or 3 criteria, with antibiotic therapy restricted to patients with all 4 findings and those with positive test results.
    • Empiric antibiotic therapy for patients with 3 or 4 criteria; no diagnostic testing.
  • Cultures are not recommended for routine evaluation of adult pharyngitis or for confirmation of negative results on rapid antigen tests if test sensitivity >80%.
  • Throat cultures maybe useful for outbreak investigation, monitoring rates of antibiotic resistance, or when other pathogens (e.g., gonococcus) are being considered.

 

Comparison of
Diagnostic Strategies*
 
Test for 2+
criteria and
treat positives
Empiric treatment for 3-4 criteria
% of patients
with GABHS who are correctly
treated
60%-70%
70%-80%
% of patients
receiving antibiotics
11%
33%

*Assumptions: RAT sensitivity = 80%; RAT specificity = 90%; GABHS prevalence = 10%.

 

Treatment
Penicillin is recommended for initial treatment of GABHS.
Erythromycin is recommended for penicillin-allergic patients.
Penicillin-resistant GABHS have not been reported in the United States.
Extended spectrum macrolides and fluoroquinolones are not appropriate for uncomplicated GABHS pharyngitis.
TIPS TO REDUCE
ANTIBIOTIC USE
Tell patients that antibiotic use increases the risk of an antibioticresistant infection.
Identify and validate patient concerns.
Recommend specific
symptomatic therapy.
Spend time answering questions and offer a contingency plan if symptoms worsen.
Provide patient education materials on antibiotic resistance.
REMEMBER: Effective communication is more important than an antibiotic for patient satisfaction.
See www.cdc.gov/
drugresistance/
community
or contact your local health department for more information and patient education materials.

 

Key Reference
Cooper RJ et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: Background. Annals of Internal Medicine 2001;134(6):509-17.

 

 
 

 

 
 
Date: April 6, 2006
Content source: National Center for Immunization and Respiratory Diseases / Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
 Safer, Healthier People  USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435